ZNF519 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.705200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.426600E-01
Normal-vs-Stage2
4.736000E-01
Normal-vs-Stage3
2.701600E-01
Normal-vs-Stage4
5.811800E-01
Stage1-vs-Stage2
3.298800E-01
Stage1-vs-Stage3
3.339900E-02
Stage1-vs-Stage4
9.510200E-01
Stage2-vs-Stage3
4.189600E-02
Stage2-vs-Stage4
3.737000E-01
Stage3-vs-Stage4
1.011430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.827800E-01
Normal-vs-AfricanAmerican
4.050400E-01
Normal-vs-Asian
3.633600E-01
Caucasian-vs-AfricanAmerican
4.367400E-01
Caucasian-vs-Asian
1.047380E-01
AfricanAmerican-vs-Asian
6.428000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.549400E-01
Normal-vs-Female
4.941800E-01
Male-vs-Female
3.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.356600E-01
Normal-vs-Age(41-60Yrs)
5.208200E-01
Normal-vs-Age(61-80Yrs)
4.424800E-01
Normal-vs-Age(81-100Yrs)
4.818600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.807000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.336560E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.767600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.829800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.161600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.854200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.502200E-01
Normal-vs-Daily Drinker
4.217200E-01
Normal-vs-Weekly Drinker
4.127000E-01
Normal-vs-Occasional Drinker
4.149600E-01
Normal-vs-Social Drinker
6.804800E-01
Non Drinker-vs-Daily Drinker
6.785000E-01
Non Drinker-vs-Weekly Drinker
6.065400E-01
Non Drinker-vs-Occasional Drinker
6.035200E-01
Non Drinker-vs-Social Drinker
3.811600E-02
Daily Drinker-vs-Weekly Drinker
9.165000E-01
Daily Drinker-vs-Occasional Drinker
9.408400E-01
Daily Drinker-vs-Social Drinker
3.178300E-02
Weekly Drinker-vs-Occasional Drinker
9.648800E-01
Weekly Drinker-vs-Social Drinker
2.733900E-02
Occasional Drinker-vs-Social Drinker
1.794150E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.298800E-01
Normal-vs-Grade 2
7.420200E-02
Normal-vs-Grade 3
1.201160E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.476000E-01
Grade 1-vs-Grade 3
3.613600E-01
Grade 1-vs-Grade 4
2.298800E-01
Grade 2-vs-Grade 3
6.311200E-01
Grade 2-vs-Grade 4
7.420200E-02
Grade 3-vs-Grade 4
1.201160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.144600E-01
Normal-vs-NonDiabetic
4.726400E-01
Diabetic-vs-NonDiabetic
2.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.577600E-01
Normal-vs-NoPancreatitis
4.538000E-01
Pancreatitis-vs-NoPancreatitis
9.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.661000E-01
Normal-vs-N1
4.746400E-01
N0-vs-N1
8.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.195600E-01
Normal-vs-TP53-NonMutant
6.016000E-01
TP53-Mutant-vs-TP53-NonMutant
7.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
